Adasuve: FDA Approves First Inhaled Treatment For Schizophrenia And Bipolar Disorder (WELLNESS)
Dec 21 (Reuters) - Alexza Pharmaceuticals Inc said the U.S. health regulators approved Adasuve, making it the first treatment